Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
2010-2019
Title
Created Date
Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells
25 February 2022
Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme
24 February 2022
S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications
23 February 2022
Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications
19 February 2022
The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation
08 February 2022
Melatonin treatment increases the transcription of cell proliferation-related genes prior to inducing cell death in C6 glioma cells in vitro
04 February 2022
Vitamin D: a novel player in endothelial function and dysfunction
03 February 2022
Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells
28 January 2022
Prolactin Promotes Breast Cancer Cell Migration through Actin Cytoskeleton Remodeling
27 January 2022
Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERalpha and STAT5
24 January 2022
Display #
5
10
15
20
25
30
50
100
All
Page 15 of 173
Start
Prev
10
11
12
13
14
15
16
17
18
19
Next
End
Search
Follow us...
Latest
Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin
TARGETING TUMOR ASSOCIATED MACROPHAGES (TAMS) FOR CANCER TREATMENT: EXPLOITING MELATONIN AS BIOLOGICAL RESPONSE MODIFIER (BRM)
SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma
PROMISING COMPOUNDS WITH HEALTH BENEFITS: PHYTOMELATONIN AND MELATONIN
Understanding the role of melatonin in cancer metabolism
Melatonin: an essential factor for the treatment and recovery from leukemia and cancer
Radioprotective effects of melatonin on radiation-induced cataract
Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy
Radiation-Induced Dual Oxidase Upregulation in Rat Heart Tissues: Protective Effect of Melatonin
Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats
Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis
Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines
Targeting Growth Hormone Receptor to Overcome Therapy Resistance in Non-Small Cell Lung Cancer
Dopamine D2 Receptor Agonists as Modulators of VEGF-A-Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities
[68Ga]Ga-DOTA-TOC positron emission tomography outperforms [18F]FDOPA and [18F]FDG PET in pediatric neuroblastoma imaging: a prospective study
Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Bibliography
Complete objective response to biological therapy of plurifocal breast carcinoma
How effective is chemo therapy?
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Vademecum
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer